Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17Thoracic 7Head & Neck 5Breast 4Gynecologic 3Sarcoma 2Dermatologic 2Tumor-Agnostic 1Plasma cell 1Lymphoid 1Genitourinary 1Endocrine 1CNS 1

Conditions

Neurofibrosarcoma 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm, Residual 1Gastrointestinal Stromal Tumors 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Liquid Biopsy × Sarcoma × Clear all
NCT06515860 2026-01-09

NF1-TED

Boston Children's Hospital

Recruiting
1,000 enrolled
CNSSarcoma

Neurofibromatosis 1, Neurofibroma, Plexiform, Neurofibrosarcoma

NCT05408897 2022-09-21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Peking University People's Hospital

Recruiting
45 enrolled
GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡